App-Quantinova.ai

Rationalizing the Use of MRI of the Scalp Arteries in the Diagnosis of Giant Cell Arteritis Through Multivariable Predictive Modelling

Angela Hu - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

Real-World Evidence Associated with the Treatment of Systemic Lupus Erythematosus in the USA, UK, France, and Germany: A Structured Review

Pamela Berry - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Belimumab

Real-World Remission Outcomes in the First Year Following RA Diagnosis Vary Considerably with the Disease Activity Index Used and a Sizable Proportion Have Persistent Active Disease Across All Measures: Results from the Canadian Early Arthritis Cohort (CATCH)

Susan J. Bartlett - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Reasons for Initiation of Canakinumab of Patients with Systemic Juvenile Idiopathic Arthritis: A Retrospective Medical Chart Review from the United States

Raluca Ionescu-Ittu - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

canakinumab (SC)

Recent Use, Missed Doses and Discontinuation of Infliximab in a Population-Based Cohort: Comparisons of Biosimilar and Originator Exposures

Cristiano S. Moura - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Ankylosing spondylitis

Infliximab Biosimilar

Recommendation on Colchicine Dosing and Definition of Colchicine Resistance/Intolerance in the Management of Familial Mediterranean Fever

Erdal Sag - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Familial Mediterranean fever

Colchicine

Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies

Andrew Bushmakin - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies

Andrew Bushmakin - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Replacement of Radiographic Sacroilitis by MRI Structural Lesions: What Is the Impact on Classification of Axial Spondyloarthritis in the ASAS Classification Cohort?

Pedro Machado - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Resolution of Enthesitis and Dactylitis Is Maintained over Two Years of Ixekizumab Treatment in Patients with Psoriatic Arthritis

Lihi Eder - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Adalimumab

Response to Placebo in Randomized Clinical Trials with Biologics in Non-renal, Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Pooled Analysis

Laura Wakani - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Neuropsychiatric systemic lupus erythematosus

N/A

Rheumatic Immune Related Adverse Events Associated with Cancer Immunotherapy: A Nationwide Multi-centre Canadian Cohort from the Canadian Research Group of Rheumatology in Immuno-oncology (CanRIO)

Daniel Ennis - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Risk Factors Associated with Serious Infections Among Users of Biosimilar and Originator Infliximab Therapies

Cristiano S. Moura - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Ankylosing spondylitis

Infliximab Biosimilar

Risk of Cardiovascular Disease Associated with the Use of Glucocorticoids in Patients with Incident Systemic Lupus Erytematosus: A Population-based Study

Hui Xie - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

Glucocorticoid

Risk of Serious Infections in Offspring According to TNFi Subtypes

Yvan St-Pierre - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Ankylosing spondylitis

N/A

Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Initiating Biologic and Non-biologic DMARDs, a Population-based Study

Na Lu - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Romosozumab Improves Lumbar Spine Bone Mineral Density and Bone Strength Greater Than Alendronate as Assessed by Quantitative Computed Tomography and Finite Element Analysis in the ARCH Trial

Arkadi Chines - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Alendronate sodium

Safety and Effectiveness of Upadacitinib or Adalimumab in Patients with Rheumatoid Arthritis: Results at 48 Weeks

Jose Jeffrey Enejosa - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

ABT-494

Safety and Efficacy Results from the Open Label Extension of a Phase 2 Trial of Risankizumab, a Selective IL-23p19 Inhibitor in Patients with Active Psoriatic Arthritis

Melinda Gooderham - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Risankizumab

Safety Profile of Ixekizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis: Integrated Analysis of 18 Clinical Trials

Hideto Kameda - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Inflammatory bowel disease

LY2439821

Filters

28841 Abstracts